Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review
Achille Aveta,
Vincenzo Iossa,
Gianluca Spena,
Paolo Conforti,
Giovanni Pagano,
Fabrizio Dinacci,
Paolo Verze,
Celeste Manfredi,
Matteo Ferro,
Francesco Lasorsa,
Lorenzo Spirito,
Luigi Napolitano,
Antonio Tufano,
Alessandra Fiorenza,
Pierluigi Russo,
Fabio Crocerossa,
Giuseppe Lucarelli,
Sisto Perdonà,
Roberto Sanseverino,
Salvatore Siracusano,
Simone Cilio,
Savio Domenico Pandolfo
Affiliations
Achille Aveta
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Vincenzo Iossa
Department of Urology, Umberto I Hospital, ASL Salerno, 84014 Nocera Inferiore, Italy
Gianluca Spena
Department of Urology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, 80131 Naples, Italy
Paolo Conforti
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Giovanni Pagano
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Fabrizio Dinacci
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Paolo Verze
Department of Medicine and Surgery, Scuola Medica Salernitana, University of Salerno, 84081 Fisciano, Italy
Celeste Manfredi
Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy
Matteo Ferro
Division of Urology, European Institute of Oncology, IRCCS, 71013 Milan, Italy
Francesco Lasorsa
Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari “Aldo Moro”, 70124 Bari, Italy
Lorenzo Spirito
Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy
Luigi Napolitano
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Antonio Tufano
Department of Urology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, 80131 Naples, Italy
Alessandra Fiorenza
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Pierluigi Russo
Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli, Largo Francesco Vito 1, 00168 Rome, Italy
Fabio Crocerossa
Division of Urology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy
Giuseppe Lucarelli
Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari “Aldo Moro”, 70124 Bari, Italy
Sisto Perdonà
Department of Urology, Istituto Nazionale Tumori, IRCCS, “Fondazione G. Pascale”, 80131 Naples, Italy
Roberto Sanseverino
Department of Urology, Umberto I Hospital, ASL Salerno, 84014 Nocera Inferiore, Italy
Salvatore Siracusano
Department of Urology, University of L’Aquila, 67100 L’Aquila, Italy
Simone Cilio
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
Savio Domenico Pandolfo
Department of Neurosciences and Reproductive Sciences and Odontostomatology, University of Naples “Federico II”, 80131 Naples, Italy
This review focuses on ablative techniques for small renal masses (SRMs), including radiofrequency ablation (RFA), cryoablation (CA), microwave ablation (MWA), and irreversible electroporation (IRE), and discusses recurrence management. Through an extensive literature review, we outline the procedures, outcomes, and follow-up strategies associated with each ablative method. The review provides a detailed examination of these techniques—RFA, CA, MWA, and IRE—elucidating their respective outcomes. Recurrence rates vary among them, with RFA and CA showing comparable rates, MWA demonstrating favorable short-term results, and IRE exhibiting promise in experimental stages. For managing recurrences, various strategies are considered, including active surveillance, re-ablation, or salvage surgery. Surveillance is preferred post-RFA and post-CA, due to slow SRM growth, while re-ablation, particularly with RFA and CA, is deemed feasible without additional complications. Salvage surgery emerges as a viable option for larger or resistant tumors. While ablative techniques offer short-term results comparable to surgery, further research is essential to understand their long-term effects fully. Decisions concerning recurrence management should consider individual and tumor-specific factors. Imaging, notably contrast-enhanced ultrasounds, plays a pivotal role in assessing treatment success, emphasizing the necessity of a multidisciplinary approach for optimal outcomes. The lack of randomized trials highlights the need for further research.